Vaccine Developers Promise Diversity in Clinical Trials

July 31, 2020

Vaccine Developers Promise Diversity in Clinical Trials

Coronavirus vaccine developers have pledged their commitment to diversity in clinical trials. "Ensuring diversity in these trials, including in terms of race, ethnicity, gender, age, and other factors, is a priority in our efforts," said Menelas Pangalos, AstraZeneca Plc's executive vice president of biopharmaceutical research & development. With an extensive global network and a direct-to-patient service offering, Yourway can bring trial supplies around the world in hours, not days.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

Schedule a Meeting

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Schedule a Meeting

Media

Articles

White-Glove by Design: The Yourway Standard in Clinical Logistics

Open chat

Hello! How can I help you?